These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11167042)

  • 1. Rapid relaxation times measurements by MRI: an in vivo application to contrast agent modeling for muscle fiber types characterization.
    Dedieu V; Fau P; Otal P; Renou JP; Emerit V; Joffre F; Vincensini D
    Magn Reson Imaging; 2000 Dec; 18(10):1221-33. PubMed ID: 11167042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tissue extracellular volume fraction measurement by dynamic spin-lattice MRI relaxometry: application to the characterization of muscle fiber types.
    Dedieu V; Finat-Duclos F; Renou JP; Joffre F; Vincensini D
    Invest Radiol; 1999 Mar; 34(3):185-9. PubMed ID: 10084661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of high-resolution magic-angle spinning NMR spectroscopy to define the cell uptake of MRI contrast agents.
    Calabi L; Alfieri G; Biondi L; De Miranda M; Paleari L; Ghelli S
    J Magn Reson; 2002 Jun; 156(2):222-9. PubMed ID: 12165257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of saturation-recovery dynamic contrast-enhanced MRI acquisition protocol: monte carlo simulation approach demonstrated with gadolinium MR renography.
    Zhang JL; Conlin CC; Carlston K; Xie L; Kim D; Morrell G; Morton K; Lee VS
    NMR Biomed; 2016 Jul; 29(7):969-77. PubMed ID: 27200499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles.
    Vincensini D; Dedieu V; Renou JP; Otal P; Joffre F
    Magn Reson Imaging; 2003 Feb; 21(2):85-93. PubMed ID: 12670594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
    Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO
    Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
    Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
    Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.
    Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M
    Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
    Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G
    Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
    Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y
    Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.